all names

Christopher Oreilly person

Named in 3 reports across 3 stories - 28 Aug – 15 Oct
28 Aug 202615 Oct 2026

Closest companions, sized by how often they share a report with Christopher Oreilly. Lines between the outer names are their own relationships - names that appear together even without Christopher Oreilly.

Japan and Japanese share 3 reportsOsaka and Tsuyoshi Tada share 3 reportsExchange Commission and Osaka share 3 reportsOsaka and Takeda Pharmaceutical Company Limited Takeda share 3 reportsTakeda Pharmaceutical Company Limited Takeda and Tsuyoshi Tada share 3 reportsJapan and Takeda Pharmaceutical Company Limited Takeda share 3 reportsExchange Commission and Japan share 3 reportsExchange Commission and Tsuyoshi Tada share 3 reportsJapan and Osaka share 3 reportsExchange Commission and Takeda Pharmaceutical Company Limited Takeda share 3 reportsJapanese and Osaka share 3 reportsJapan and Tsuyoshi Tada share 3 reportsJapanese and Tsuyoshi Tada share 3 reportsJapanese and Takeda Pharmaceutical Company Limited Takeda share 3 reportsExchange Commission and Japanese share 3 reportsDrug Administration and Japan share 2 reportsDrug Administration and Tsuyoshi Tada share 2 reportsOsaka and Takeda Pharmaceuticals share 2 reportsChina and Takeda Pharmaceutical Company Limited Takeda share 2 reportsChina and Osaka share 2 reportsTakeda Pharmaceuticals and Tsuyoshi Tada share 2 reportsChina and Tsuyoshi Tada share 2 reportsTakeda Pharmaceutical Company Limited Takeda and Takeda Pharmaceuticals share 2 reportsDrug Administration and Osaka share 2 reportsDrug Administration and Japanese share 2 reportsJapanese and Takeda Pharmaceuticals share 2 reportsJapan and Takeda Pharmaceuticals share 2 reportsChina and Exchange Commission share 2 reportsDrug Administration and Takeda Pharmaceutical Company Limited Takeda share 2 reportsChina and Japanese share 2 reportsChina and Japan share 2 reportsDrug Administration and Exchange Commission share 2 reportsExchange Commission and Takeda Pharmaceuticals share 2 reportsAccess Program and Takeda Pharmaceuticals share 1 reportAccess Program and Japanese share 1 reportChina and Takeda Pharmaceuticals share 1 reportChina and Drug Administration share 1 reportAccess Program and Tsuyoshi Tada share 1 reportAccess Program and China share 1 reportAccess Program and Takeda Pharmaceutical Company Limited Takeda share 1 reportChristopher OreillyExchange Commissi…Exchange Commission - 3 shared reports (organization)JapanJapan - 3 shared reports (place)JapaneseJapanese - 3 shared reports (place)OsakaOsaka - 3 shared reports (place)Takeda Phar…Takeda Pharmaceutical Company Limited Takeda - 3 shared reports (organization)Tsuyoshi TadaTsuyoshi Tada - 3 shared reports (person)ChinaChina - 2 shared reports (place)Drug Admini…Drug Administration - 2 shared reports (organization)Takeda Phar…Takeda Pharmaceuticals - 2 shared reports (organization)Access Prog…Access Program - 1 shared report (organization)

The stories

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

82 outlets1 report names Christopher Oreilly5 Aug – 17 Nov

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

1 outlets1 report names Christopher Oreilly15 Oct

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera

1 outlets1 report names Christopher Oreilly28 Aug

Who keeps naming them

owensoundsuntimes.com1intelligencer.ca1theobserver.ca1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.